COMP <GO>
IMA vs TIL // EV/EBITDA & P/E VALUATION
ImageneBio Inc. (NASDAQ) VS. Instil Bio Inc. (NASDAQ) • 15-METRIC TALLY: IMA 0
— TIL 3
■ METRIC PARITY
LAST: $4.05 (-3.57%) • MKT CAP: $46.0M
valuation
—
LAST: $6.83 (+0.52%) • MKT CAP: $46.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMA VS. TIL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMA | TIL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 3/9 | -2.00 | TIL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 56.4 | -16.13 | TIL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.0M | $46.3M | -$313.6K | TIL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMA REV | TIL REV | IMA GROSS % | TIL GROSS % | IMA FCF | TIL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $800.0K | $0 | — | — | -$47.8M | -$36.6M |
| FY 2024 | $3.5M | $0 | — | — | -$21.3M | -$55.7M |
| FY 2023 | $9.2M | $0 | — | — | -$79.7M | -$82.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMA // BETA —
TIL // BETA —